Research and Development

Drugmakers Repurpose Existing Therapies for COVID-19

Drugmakers are scouring their product portfolios for possible COVID-19 treatments and some are showing potential. Read More

FDA Coordinates Nationwide Effort on Blood-Based Therapies for COVID-19

The FDA is promoting a nationwide effort to investigate two blood-based therapies for treatment of COVID-19. Read More

Amgen and Adaptive Biotechnologies Partner on COVID-19 Therapeutic

April 3, 2020

The companies said they will finalize the financial details in the coming weeks. Read More

Novartis Plans Clinical Trial of Jakavi in Severe COVID-19 Patients

April 3, 2020

The drug is approved in more than 100 countries for patients with myelofibrosis. Read More

Emergent BioSolutions Partners with HHS for Plasma-Derived COVID-19 Treatment

April 3, 2020

The National Institutes of Health also agreed to incorporate COVID-HIG into one of its clinical trials. Read More

Chinese Trial Suggests Hydroxychloroquine Helps COVID-19 Patients

The anti-malaria drug hydroxychloroquine was effective in treating COVID-19 patients in China, according to early data from a small clinical trial. Read More

Big Tobacco has COVID-19 Vaccine Candidates in the Pipeline

Philip Morris and British American Tobacco (BAT) have entered the race for a COVID-19 vaccine in collaboration with two biotech firms working on plant-based vaccines. Read More

Gilead Begins Remdesivir Trials in the U.K.

Gilead has initiated two phase 3 clinical trials in the U.K. to test remdesivir for treatment of patients with COVID-19. Read More

Australia Begins Testing COVID-19 Vaccines

April 2, 2020

CSIRO was the first research organization outside of China to generate sufficient stock of the virus to enable pre-clinical studies of COVID-19. Read More